Did Treasury Target Pfizer-Allergan Inversion?
Socially Responsible Companies Pay Lower Taxes
Clinton to Propose Crackdown on Inversions
Finance Roundup for Executives
Pfizer Buys Allergan for $160B
Strong Dollar Deflates Earnings
Mergers and Acquisitions: Coming Unstuck
Treasury Proposal Would Thwart Corporate Inversions
Divestitures Can Spawn Costly Human-Capital Errors
Financing Medical Research: Disease or Cure?
The Prescription for Pharma Is Revenue Growth
Pfizer Defiant